Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus?

Nature Reviews Microbiology

Volumn 9, Issue 3, 2011, Pages 215-222

  Thwaites, Guy E ^a   Gant, Vanya ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; FLUCLOXACILLIN; GENTAMICIN; LINEZOLID; MOXIFLOXACIN; NAFCILLIN; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

BACTERIAL CELL; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BLOOD FLOW; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; IN VIVO STUDY; METASTASIS; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; HUMANS; LEUKOCYTES; PHAGOCYTES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); EQUIDAE; STAPHYLOCOCCUS AUREUS;

EID: 79951852718     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro2508     Document Type: Review

References (103)

1. Lowy, F. D. Staphylococcus aureus infections. N. Engl. J. Med. 339, 520-532 (1998).
2. Gorwitz, R. J. et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J. Infect. Dis. 197, 1226-1234 (2008). (Pubitemid 351632753)
3. Wenzel, R. P. & Perl, T. M. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J. Hosp. Infect. 31, 13-24 (1995).
4. Shorr, A. F. et al. Healthcare-associated bloodstream infection: A distinct entity? Insights from a large US database. Crit. Care Med. 34, 2588-2595 (2006). (Pubitemid 44413057)
5. Health Protection Agency. Summary points on April to June 2009 quarterly data and financial year (April 2008 to March 2009) for MRSA bacteraemia Mandatory Surveillance data, September 2009. Health Protection Agency [online] http://www.hpa.org. uk/web/HPAwebFile/HPAweb-C/1229502459877 (2009).
6. Wyllie, D. H., Crook, D. W. & Peto, T. E. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 333, 281 (2006).
7. Chang, F. Y. et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 82, 322-332 (2003).
8. Fowler, V. G. Jr et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch. Intern. Med. 163, 2066-2072 (2003). (Pubitemid 37151249)
9. Khatib, R. et al. Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome. Scand. J. Infect. Dis. 38, 7-14 (2006). (Pubitemid 43123837)
10. Chu, V. H. et al. Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. Am. J. Med. 118, 1416 (2005).
11. Lalani, T. et al. Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infections. Scand. J. Infect. Dis. 40, 973-977 (2008).
12. Cosgrove, S. E. & Fowler, V. G. Jr. Management of methicillin-resistant Staphylococcus aureus bacteremia. Clin. Infect. Dis. 46 (Suppl. 5), S386-S393 (2008). (Pubitemid 351717326)
13. Turnidge, J. D. et al. Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med. J. Aust. 191, 368-373 (2009).
14. Khatib, R. et al. Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time. Scand. J. Infect. Dis. 41, 4-9 (2009).
15. Alexander, E. H. & Hudson, M. C. Factors influencing the internalization of Staphylococcus aureus and impacts on the course of infections in humans. Appl. Microbiol. Biotechnol. 56, 361-366 (2001). (Pubitemid 32763345)
16. Garzoni, C. & Kelley, W. L. Staphylococcus aureus: new evidence for intracellular persistence. Trends Microbiol. 17, 59-65 (2009).
17. Sinha, B. & Fraunholz, M. Staphylococcus aureus host cell invasion and post-invasion events. Int. J. Med. Microbiol. 300, 170-175 (2010).
18. Sinha, B. & Herrmann, M. Mechanism and consequences of invasion of endothelial cells by Staphylococcus aureus. Thromb. Haemost. 94, 266-277 (2005). (Pubitemid 41122480)
19. Lowy, F. D. Is Staphylococcus aureus an intracellular pathogen? Trends Microbiol. 8, 341-343 (2000). (Pubitemid 30628945)
20. Sendi, P. & Proctor, R. A. Staphylococcus aureus as an intracellular pathogen: the role of small colony variants. Trends Microbiol. 17, 54-58 (2009).
21. Hall-Stoodley, L. & Stoodley, P. Evolving concepts in biofilm infections. Cell. Microbiol. 11, 1034-1043 (2009).
22. Foster, T. J. Immune evasion by staphylococci. Nature Rev. Microbiol. 3, 948-958 (2005). (Pubitemid 43078158)
23. DeLeo, F. R., Diep, B. A. & Otto, M. Host defense and pathogenesis in Staphylococcus aureus infections. Infect. Dis. Clin. North Am. 23, 17-34 (2009).
24. Anwar, S., Prince, L. R., Foster, S. J., Whyte, M. K. & Sabroe, I. The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes. Clin. Exp. Immunol. 157, 216-224 (2009).
25. Van de Velde, H. Etude sur le mécanisme de la virulence du staphylocoque pyogène. La Cellule 10, 401-460 (1894) (in French).
26. Rogers, D. E. & Tompsett, R. The survival of staphylococci within human leukocytes. J. Exp. Med. 95, 209-230 (1952).
27. Kapral, F. A. & Shayegani, M. G. Intracellular survival of staphylococci. J. Exp. Med. 110, 123-138 (1959).
28. Melly, M. A., Thomison, J. B. & Rogers, D. E. Fate of staphylococci within human leukocytes. J. Exp. Med. 112, 1121-1130 (1960).
29. Rogers, D. E. & Melly, M. A. Further observations on the behavior of staphylococci within human leukocytes. J. Exp. Med. 111, 533-558 (1960).
30. Kubica, M. et al. A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS ONE 3, e1409 (2008).
31. Rooijakkers, S. H., van Kessel, K. P. & van Strijp, J. A. Staphylococcal innate immune evasion. Trends Microbiol. 13, 596-601 (2005). (Pubitemid 41661341)
32. Serruto, D., Rappuoli, R., Scarselli, M., Gros, P. & van Strijp, J. A. Molecular mechanisms of complement evasion: learning from staphylococci and meningococci. Nature Rev. Microbiol. 8, 393-399 (2010).
33. O'Riordan, K. & Lee, J. C. Staphylococcus aureus capsular polysaccharides. Clin. Microbiol. Rev. 17, 218-234 (2004). (Pubitemid 38120935)
34. Foster, T. J. Colonization and infection of the human host by staphylococci: adhesion, survival and immune evasion. Vet. Dermatol. 20, 456-470 (2009).
35. Das, D. & Bishayi, B. Staphylococcal catalase protects intracellularly survived bacteria by destroying H2O2 produced by the murine peritoneal macrophages. Microb. Pathog. 47, 57-67 (2009).
36. Olivier, A. C., Lemaire, S., Van Bambeke, F., Tulkens, P. M. & Oldfield, E. Role of rsbU and staphyloxanthin in phagocytosis and intracellular growth of Staphylococcus aureus in human macrophages and endothelial cells. J. Infect. Dis. 200, 1367-1370 (2009).
37. Liu, G. Y. et al. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J. Exp. Med. 202, 209-215 (2005). (Pubitemid 41043816)
38. Cheung, A. L., Bayer, A. S., Zhang, G., Gresham, H. & Xiong, Y. Q. Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol. Med. Microbiol. 40, 1-9 (2004). (Pubitemid 38083352)
39. Cheung, A. L., Nishina, K. A., Trotonda, M. P. & Tamber, S. The SarA protein family of Staphylococcus aureus. Int. J. Biochem. Cell Biol. 40, 355-361 (2008).
40. Wesson, C. A. et al. Staphylococcus aureus Agr and Sar global regulators influence internalization and induction of apoptosis. Infect. Immun. 66, 5238-5243 (1998). (Pubitemid 29044615)
41. Shompole, S. et al. Biphasic intracellular expression of Staphylococcus aureus virulence factors and evidence for Agr-mediated diffusion sensing. Mol. Microbiol. 49, 919-927 (2003). (Pubitemid 36981339)
42. Heyer, G. et al. Staphylococcus aureus agr and sarA functions are required for invasive infection but not inflammatory responses in the lung. Infect. Immun. 70, 127-133 (2002). (Pubitemid 34028608)
43. Voyich, J. M. et al. The SaeR/S gene regulatory system is essential for innate immune evasion by Staphylococcus aureus. J. Infect. Dis. 199, 1698-1706 (2009).
44. Bayles, K. W. et al. Intracellular Staphylococcus aureus escapes the endosome and induces apoptosis in epithelial cells. Infect. Immun. 66, 336-342 (1998). (Pubitemid 28018838)
45. Lam, T. T. et al. Phagolysosomal integrity is generally maintained after Staphylococcus aureus invasion of nonprofessional phagocytes but is modulated by strain 6850. Infect. Immun. 78, 3392-3403 (2010).
46. Voyich, J. M. et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J. Immunol. 175, 3907-3919 (2005). (Pubitemid 41292051)
47. Gresham, H. D. et al. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J. Immunol. 164, 3713-3722 (2000). (Pubitemid 30169827)
48. Kobayashi, S. D. et al. Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc. Natl Acad. Sci. USA 100, 10948-10953 (2003). (Pubitemid 37140133)
49. Koziel, J. et al. Phagocytosis of Staphylococcus aureus by macrophages exerts cytoprotective effects manifested by the upregulation of antiapoptotic factors. PLoS ONE 4, e5210 (2009).
50. Ocana, M. G. et al. Autoregulation mechanism of human neutrophil apoptosis during bacterial infection. Mol. Immunol. 45, 2087-2096 (2008). (Pubitemid 351226262)
51. Craven, N. & Anderson, J. C. The location of Staphylococcus aureus in experimental chronic mastitis in the mouse and the effect on the action of sodium cloxacillin. Br. J. Exp. Pathol. 60, 453-459 (1979). (Pubitemid 10200277)
52. Craven, N. & Anderson, J. C. Antibiotic activity against intraleukocytic Staphylococcus aureus in vitro and in experimental mastitis in mice. Am. J. Vet. Res. 44, 709-712 (1983). (Pubitemid 13108121)
53. McLoughlin, R. M. et al. CD4+ T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infections. Proc. Natl Acad. Sci. USA 103, 10408-10413 (2006). (Pubitemid 44051180)
54. Beam, T. R. Jr. Sequestration of staphylococci at an inaccessible focus. Lancet 2, 227-228 (1979). (Pubitemid 9234840)
55. Buggy, B. P., Schaberg, D. R. & Swartz, R. D. Intraleukocytic sequestration as a cause of persistent Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis. Am. J. Med. 76, 1035-1040 (1984). (Pubitemid 14120409)
56. Clement, S. et al. Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J. Infect. Dis. 192, 1023-1028 (2005). (Pubitemid 41266799)
57. Sachse, F., Becker, K., von Eiff, C., Metze, D. & Rudack, C. Staphylococcus aureus invades the epithelium in nasal polyposis and induces IL-6 in nasal epithelial cells in vitro. Allergy 65, 1430-1437 (2010).
58. Zautner, A. E. et al. Intracellular persisting Staphylococcus aureus is the major pathogen in recurrent tonsillitis. PLoS ONE 5, e9452 (2010).
59. Davis, J. M. & Ramakrishnan, L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136, 37-49 (2009).
60. Drevets, D. A. Dissemination of Listeria monocytogenes by infected phagocytes. Infect. Immun. 67, 3512-3517 (1999). (Pubitemid 29291523)
61. Rogers, D. E. Studies on bacteraemia, I. Mechanisms relating to the persistence of bacteraemia in rabbits following the intravenous injection of staphylococci. J. Exp. Med. 103, 713-742 (1956).
62. Derby, B. M. & Rogers, D. E. Studies on bacteriemia. V. The effect of simultaneous leukopenia and reticuloendothelial blockade on the early blood stream clearance of staphylococci and Escherichia coli. J. Exp. Med. 113, 1053-1066 (1961).
63. Velasco, E. et al. Comparative study of clinical characteristics of neutropenic and non-neutropenic adult cancer patients with bloodstream infections. Eur. J. Clin. Microbiol. Infect. Dis. 25, 1-7 (2006). (Pubitemid 43207321)
64. Venditti, M. et al. Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study. Haematologica 88, 923-930 (2003).
65. Fowler, V. G. Jr et al. Persistent bacteremia due to methicillin- resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J. Infect. Dis. 190, 1140-1149 (2004). (Pubitemid 39186802)
66. Xiong, Y. Q. et al. Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis model. J. Infect. Dis. 199, 201-208 (2009).
67. Dhawan, V. K., Bayer, A. S. & Yeaman, M. R. In vitro resistance to thrombin-induced platelet microbicidal protein is associated with enhanced progression and hematogenous dissemination in experimental Staphylococcus aureus infective endocarditis. Infect. Immun. 66, 3476-3479 (1998). (Pubitemid 28303159)
68. Rous, P. & Jones, F. S. The protection of pathogenic microorganisms by living tissue cells. J. Exp. Med. 23, 601-612 (1916).
69. Magoffin, R. L. & Spink, W. W. The protection of intracellular brucella against streptomycin alone and in combination with other antibiotics. J. Lab. Clin. Med. 37, 924-930 (1951).
70. Holmes, B., Quie, P. G., Windhorst, D. B., Pollara, B. & Good, R. A. Protection of phagocytized bacteria from the killing action of antibiotics. Nature 210, 1131-1132 (1966).
71. Van Bambeke, F., Barcia-Macay, M., Lemaire, S. & Tulkens, P. M. Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives. Curr. Opin. Drug Discov. Devel. 9, 218-230 (2006).
72. Dobson, P. D. & Kell, D. B. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? Nature Rev. Drug Discov. 7, 205-220 (2008). (Pubitemid 351321232)
73. Yancey, R. J., Sanchez, M. S. & Ford, C. W. Activity of antibiotics against Staphylococcus aureus within polymorphonuclear neutrophils. Eur. J. Clin. Microbiol. Infect. Dis. 10, 107-113 (1991).
74. Maurin, M. & Raoult, D. Use of aminoglycosides in treatment of infections due to intracellular bacteria. Antimicrob. Agents Chemother. 45, 2977-2986, (2001). (Pubitemid 32988817)
75. Carryn, S. et al. Intracellular pharmacodynamics of antibiotics. Infect. Dis. Clin. North Am. 17, 615-634 (2003). (Pubitemid 38029156)
76. Lam, C. & Mathison, G. E. Effect of low intraphagolysosomal pH on antimicrobial activity of antibiotics against ingested staphylococci. J. Med. Microbiol. 16, 309-316 (1983). (Pubitemid 13032673)
77. Mandell, G. L. Uptake, transport, delivery, and intracellular activity of antimicrobial agents. Pharmacotherapy 25, 130S-133S (2005). (Pubitemid 41790086)
78. Mandell, G. L. Interaction of intraleukocytic bacteria and antibiotics. J. Clin. Invest. 52, 1673-1679 (1973).
79. Lam, C. & Mathison, G. E. Intraphagocytic protection of staphylococci from extracellular penicillin. J. Med. Microbiol. 15, 373-385 (1982). (Pubitemid 12031755)
80. Qazi, S. N., Harrison, S. E., Self, T., Williams, P. & Hill, P. J. Real-time monitoring of intracellular Staphylococcus aureus replication. J. Bacteriol. 186, 1065-1077 (2004). (Pubitemid 38209466)
81. Barcia-Macay, M., Seral, C., Mingeot-Leclercq, M. P., Tulkens, P. M. & Van Bambeke, F. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages. Antimicrob. Agents Chemother. 50, 841-851 (2006). (Pubitemid 43327786)
82. Lemaire, S. et al. Activities of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages and keratinocytes) forms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53, 2289-2297 (2009).
83. Sandberg, A. et al. Intra- and extracellular activities of dicloxacillin against Staphylococcus aureus in vivo and in vitro. Antimicrob. Agents Chemother. 54, 2391-2400 (2010).
84. Jensen, A. G. et al. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch. Intern. Med. 162, 25-32 (2002). (Pubitemid 34073396)
85. Hughes, D. W. et al. Continuous versus intermittent infusion of oxacillin for treatment of infective endocarditis caused by methicillin-susceptible Staphylococcus aureus. Antimicrob. Agents Chemother. 53, 2014-2019 (2009).
86. Bonventre, P. F., Hayes, R. & Imhoff, J. Autoradiographic evidence for the impermeability of mouse peritoneal macrophages to tritiated streptomycin. J. Bacteriol. 93, 445-450 (1967).
87. Bayer, A. S. & Murray, B. E. Initial low-dose aminoglycosides in Staphylococcus aureus bacteremia: good science, urban legend, or just plain toxic? Clin. Infect. Dis. 48, 722-724 (2009).
88. Baudoux, P. et al. Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections. J. Antimicrob. Chemother. 59, 246-253 (2007). (Pubitemid 47072064)
89. Mandell, G. L. & Vest, T. K. Killing of intraleukocytic Staphylococcus aureus by rifampin: in vitro and in vivo studies. J. Infect. Dis. 125, 486-490 (1972).
90. Tan, T. Q., Mason, E. O. Jr, Ou, C. N. & Kaplan, S. L. Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia. Antimicrob. Agents Chemother. 37, 2401-2406 (1993). (Pubitemid 23324463)
91. Ahmad, N. M. & Rojtman, A. D. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin. Ann. Pharmacother. 44, 918-921 (2010).
92. Pascual, A., Ballesta, S., Garcia, I. & Perea, E. J. Uptake and intracellular activity of linezolid in human phagocytes and nonphagocytic cells. Antimicrob. Agents Chemother. 46, 4013-4015 (2002). (Pubitemid 35403287)
93. Jang, H. C. et al. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin. Infect. Dis. 49, 395-401 (2009).
94. Elliott, T. S., Foweraker, J., Gould, F. K., Perry, J. D. & Sandoe, J. A. Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J. Antimicrob. Chemother. 54, 971-981 (2004). (Pubitemid 40136728)
95. Gemmell, C. G. et al. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J. Antimicrob. Chemother. 57, 589-608 (2006).
96. Mermel, L. A. et al. Clinical practice guidelines for the diagnosis and management of intravascular catheterrelated infection: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49, 1-45 (2009).
97. Deleo, F. R., Otto, M., Kreiswirth, B. N. & Chambers, H. F. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 375, 1557-1568 (2010).
98. Gould, I. M. Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus. Int. J. Antimicrob. Agents 31 (Suppl. 2), 1-9 (2008). (Pubitemid 351657677)
99. Appelbaum, P. C. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Int. J. Antimicrob. Agents 30, 398-408 (2007). (Pubitemid 47498971)
100. Tissari, P. et al. Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study. Lancet 375, 224-230 (2009).
101. Krause, R. et al. Comparison of fluorescence in situ hybridisation using peptide nucleic acid probes, Gram stain/acridine orange leukocyte cytospin and differential time to positivity methods for detection of catheter-related bloodstream infection in patients after haematopoietic stem cell transplantation. Clin. Microbiol. Infect. 16, 1591-1593 (2010).
102. Gordon, M. A. et al. Invasive non-typhoid salmonellae establish systemic intracellular infection in HIV-infected adults: an emerging disease pathogenesis. Clin. Infect. Dis. 50, 953-962 (2010).
103. British Society for Antimicrobial Chemotherapy. BSAC methods for antimicrobial susceptibility testing. Version 8 January 2009. BSAC [online] http://www.bsac.org.uk/Resources/BSAC/Version 8 - January 2009.pdf (2009).